Evidence map›Paper›PMID 22056672›Full record

ArticleGenes & development2011

Nkx2.2 repressor complex regulates islet β-cell specification and prevents β-to-α-cell reprogramming.

James B Papizan, Ruth A Singer, Shuen-Ing Tschen, Sangeeta Dhawan, Jessica M Friel, Susan B Hipkens, Mark A Magnuson, Anil Bhushan, Lori Sussel

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 1 synthesis or guideline pooled it, 202 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

James B PapizanDepartment of Genetics and Development, Institute of Human Nutrition, Columbia University, New York 10032, USA.
Ruth A Singer
Shuen-Ing Tschen
Sangeeta Dhawan
Jessica M Friel
Susan B Hipkens
Mark A Magnuson
Anil Bhushan
Lori Sussel
Columbia University · USUniversity of California, Los Angeles · USVanderbilt University · US

Funding

Coordinating Center for Beta Cell Biology ConsortiumU01DK072473 · NIDDK · VANDERBILT UNIVERSITY · PI MAGNUSON, MARK A · 2005 to 2014
$61.0M
Translational Biomarker Analytical Core (TBAC)P30DK063608 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DOMENICO ACCILI · 2003 to 2026
$36.7M
Transcriptional networks of pancreas endocrine cell differentiationU19DK042502 · NIDDK · VANDERBILT UNIVERSITY · PI MAGNUSON, MARK A · 2001 to 2010
$21.5M
Regulation of Pancreatic Islet Cell FateR01DK082590 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI LORI SUSSEL · 2009 to 2026
$7.3M
Genetic control of pancreatic endocrine cell developmentU01DK089523 · NIDDK · VANDERBILT UNIVERSITY · PI MAGNUSON, MARK A · 2010 to 2014
$5.3M
Cell Cycle Control Of Beta Cell MassR01DK068763 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BHUSHAN, ANIL · 2004 to 2014
$3.3M
TRANSGENIC MICE COREP01DK042502 · NIDDK · VANDERBILT UNIVERSITY · PI MAGNUSON, MARK A · 1990 to 2000
$994k
NIDDK NIH HHS DK0272504NIDDK NIH HHS DK042502NIDDK NIH HHS DK068763NIDDK NIH HHS DK072473NIDDK NIH HHS DK082590NIDDK NIH HHS P01 DK042502NIDDK NIH HHS P30 DK063608NIDDK NIH HHS P30 DK63608NIDDK NIH HHS R01 DK068763NIDDK NIH HHS R01 DK082590NIDDK NIH HHS U01 DK072473NIDDK NIH HHS U01 DK089523NIDDK NIH HHS U19 DK042502
6 · The paper itself

Abstract

Regulation of cell differentiation programs requires complex interactions between transcriptional and epigenetic networks. Elucidating the principal molecular events responsible for the establishment and maintenance of cell fate identities will provide important insights into how cell lineages are specified and maintained and will improve our ability to recapitulate cell differentiation events in vitro. In this study, we demonstrate that Nkx2.2 is part of a large repression complex in pancreatic β cells that includes DNMT3a, Grg3, and HDAC1. Mutation of the endogenous Nkx2.2 tinman (TN) domain in mice abolishes the interaction between Nkx2.2 and Grg3 and disrupts β-cell specification. Furthermore, we demonstrate that Nkx2.2 preferentially recruits Grg3 and HDAC1 to the methylated Aristaless homeobox gene (Arx) promoter in β cells. The Nkx2.2 TN mutation results in ectopic expression of Arx in β cells, causing β-to-α-cell transdifferentiation. A corresponding β-cell-specific deletion of DNMT3a is also sufficient to cause Arx-dependent β-to-α-cell reprogramming. Notably, subsequent removal of Arx in the β cells of Nkx2.2(TNmut/TNmut) mutant mice reverts the β-to-α-cell conversion, indicating that the repressor activities of Nkx2.2 on the methylated Arx promoter in β cells are the primary regulatory events required for maintaining β-cell identity.

Indexed as

AnimalsCell DifferentiationCo-Repressor ProteinsDiabetes MellitusDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3AGene Expression RegulationGhrelinGlucagonGlucagon-Secreting CellsHomeobox Protein Nkx-2.2Homeodomain ProteinsInsulinInsulin-Secreting CellsMiceMutationARX protein, mouseCo-Repressor ProteinsDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3ADNMT3A protein, humanDnmt3a protein, mouseGhrelinGlucagonHomeobox Protein Nkx-2.2Homeodomain ProteinsInsulinnkx2.2b protein, zebrafishNKX2-2 protein, humanNkx2-2 protein, mouseNuclear ProteinsProteinsTle3 protein, mouseTranscription FactorsZebrafish Proteins

Identifiers

PMID22056672
PMCPMC3219233
OpenAlexW2063944873

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.